4//SEC Filing
Aslan Fred 4
Accession 0001909362-25-000004
CIK 0001817241other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 8:44 PM ET
Size
4.8 KB
Accession
0001909362-25-000004
Insider Transaction Report
Form 4
Aslan Fred
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-10-17$6.00/sh−25,500$153,000→ 356,721 total
Footnotes (1)
- [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024.
Documents
Issuer
Artiva Biotherapeutics, Inc.
CIK 0001817241
Entity typeother
Related Parties
1- filerCIK 0001909362
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 8:44 PM ET
- Size
- 4.8 KB